Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sherman

Showing results (381-390 of 390) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 390 results.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 17, 2021
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scaleSusanne Singer, Eva Hammerlid, Iwona M Tomaszewska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2024
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US AdultsChristina A Rostad, Robert L Atmar, Emmanuel B Walter, et al.
Science (New York, N.Y.)|December 2, 2021
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domainKatherine G Nabel, Sarah A Clark, Sundaresh Shankar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2024
COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled TrialsAmy C Sherman, Jessica Tuan, Valeria D Cantos, et al.
Head & Neck|January 13, 2019
International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IVSusanne Singer, Cecilie Delphin Amdal, Eva Hammerlid, et al.
Open Forum Infectious Diseases|March 4, 2024
Neuroinvasive <i>Bacillus cereus</i> Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid LeukemiaJessica S Little, Cassie Coughlin, Candace Hsieh, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2021
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunityEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Science Translational Medicine|November 16, 2021
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged miceEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Nature Medicine|August 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2022
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Pageof 39

Showing results (381-390 of 390) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 390 results.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 17, 2021
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scaleSusanne Singer, Eva Hammerlid, Iwona M Tomaszewska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2024
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US AdultsChristina A Rostad, Robert L Atmar, Emmanuel B Walter, et al.
Science (New York, N.Y.)|December 2, 2021
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domainKatherine G Nabel, Sarah A Clark, Sundaresh Shankar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2024
COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled TrialsAmy C Sherman, Jessica Tuan, Valeria D Cantos, et al.
Head & Neck|January 13, 2019
International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IVSusanne Singer, Cecilie Delphin Amdal, Eva Hammerlid, et al.
Open Forum Infectious Diseases|March 4, 2024
Neuroinvasive <i>Bacillus cereus</i> Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid LeukemiaJessica S Little, Cassie Coughlin, Candace Hsieh, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2021
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunityEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Science Translational Medicine|November 16, 2021
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged miceEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Nature Medicine|August 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2022
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Pageof 39